ADMA Biologics ADMA Return on equity

Return on equity at other companies

AbCellera Biologics Inc.ABCL

-17.3%+2.1pp

Lifecore Biomedical, Inc.LFCR

-612.1%—

AnaptysBio, Inc.ANAB

-343.8%-1,012pp

Absci CorporationABSI

-63.9%+28.0pp

Avalo TherapeuticsAVTX

-36.3%—

AbbVieABBV

89%+32.7pp

FAQ

What is ADMA Biologics's return on equity?

ADMA Biologics (ADMA) reported return on equity of 41.9% in Q2 2026.

How has ADMA Biologics's return on equity changed year-over-year?

ADMA Biologics's return on equity decreased by 41.2% year-over-year, from 71.2% to 41.9%.

What is the long-term trend for ADMA Biologics's return on equity?

Over 5 years (2020 to 2025), ADMA Biologics's return on equity has grown at a -23.1% compound annual growth rate (CAGR), from -132.4% to 35.6%.

What does return on equity mean?

Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.